The NHS treatment page lays it out clearly: Loading phase (no neurological symptoms): 1mg every other day for two weeks, or until symptoms stop improving
GLP-1 agonist FDA-approved once-weekly 0.252.4 mg Dual GIP/GLP-1 agonist FDA-approved once-weekly 2.515 mg Triple agonist (GLP-1/GIP/glucagon) Phase 3 once-weekly 112 mg Dual GLP-1/glucagon agonist Phase 3 once-weekly trial-reported dosing Amylin analog Phase 3 once-weekly 1.24.5 mg HGH fragment preclinical/community daily 300600 mcg NNMT inhibitor preclinical oral 50-150 mg optional SubQ vial math Oral monoamine reuptake inhibitor trial dosing 0.25-0.5 mg daily Tissue Repair & Recovery Peptides Healing-focused compounds studied for tendon, ligament, muscle, and gut tissue repair
Self-administering peptide combinations without bloodwork monitoring and clinical oversight is not responsible research practice
2014;37(2):e22-23
These processes include DNA synthesis, red blood cell formation, energy production, nerve cell health, and general neurological function
More recent meta-analyses of prospective cohort studies in older adults have not found a relationship between blood cobalamin concentration or dietary vitamin B 12 intake and cognitive decline or dementia (80, 81)
